Search in:

OncoTargets and Therapy Volume 12, 2019 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Review

The Role Of Circulating Tumor DNA In Therapeutic Resistance

Chenxin Xu1 The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu Province, People’s Republic of China

Haixia Cao2 Research Center for Clinical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, People’s Republic of China

Chen Shi1 The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu Province, People’s Republic of China

Jifeng Feng1 The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu Province, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-7979-2391

Pages 9459-9471 | Published online: 08 Nov 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (9)

Claudia Parisi, Marco Tagliamento, Laila Belcaid, Mihaela Aldea, Arnaud Bayle, Jordi Remon-Masip, Antoine Italiano, David Planchard, Benjamin Besse & Fabrice Barlesi. (2023) Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications. The Journal of Liquid Biopsy 1, pages 100007.
Crossref

Tarek Assi, Rita Khoury, Rebecca Ibrahim, Maria Baz, Tony Ibrahim & Axel LE Cesne. (2023) Overview of the role of liquid biopsy in cancer management. Translational Oncology 34, pages 101702.
Crossref

Roberta Soscia, Irene Della Starza, Lucia Anna De Novi, Caterina Ilari, Michela Ansuinelli, Marzia Cavalli, Vittorio Bellomarino, Luciana Cafforio, Mariangela Di Trani, Giovanni Cazzaniga, Grazia Fazio, Alessandra Santoro, Domenico Salemi, Orietta Spinelli, Manuela Tosi, Carolina Terragna, Valentina Robustelli, Teresa Bellissimo, Gioia Colafigli, Massimo Breccia, Sabina Chiaretti, Alice Di Rocco, Maurizio Martelli, Anna Guarini, Ilaria Del Giudice & Robin Foà. (2022) Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases. Hematological Oncology 41:1, pages 50-60.
Crossref

Ryan J. Hartmaier, Aleksandra A. Markovets, Myung Ju Ahn, Lecia V. Sequist, Ji-Youn Han, Byoung Chul Cho, Helena A. Yu, Sang-We Kim, James Chih-Hsin Yang, Jong-Seok Lee, Wu-Chou Su, Dariusz M. Kowalski, Sergey Orlov, Song Ren, Paul Frewer, Xiaoling Ou, Darren A.E. Cross, Nisha Kurian, Mireille Cantarini & Pasi A. Jänne. (2023) Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTON . Cancer Discovery 13:1, pages 98-113.
Crossref

Hiroshi Kobayashi. (2022) Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review. Heliyon 8:11, pages e11487.
Crossref

Seth Kwabena Amponsah & Ismaila Adams. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors 121 141 .

Michael A. Cannarile, Bruno Gomes, Marta Canamero, Bernhard Reis, Allyson Byrd, Jehad Charo, Mahesh Yadav & Vaios Karanikas. (2021) Biomarker Technologies to Support Early Clinical Immuno-oncology Development: Advances and Interpretation. Clinical Cancer Research 27:15, pages 4147-4159.
Crossref

Antonio Ieni, Roberto Vita, Cristina Pizzimenti, Salvatore Benvenga & Giovanni Tuccari. (2021) Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine. Journal of Personalized Medicine 11:5, pages 333.
Crossref

Bing Xu, Anu Amallraja, Padmapriya Swaminathan, Rachel Elsey, Christel Davis, Stephanie Theel, Sarah Viet, Jason Petersen, Amy Krie, Gareth Davies, Casey B. Williams, Erik Ehli & Tobias Meißner. (2020) Case report: 16-yr life history and genomic evolution of an ER + HER2 − breast cancer . Molecular Case Studies 6:6, pages a005629.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The Role Of Circulating Tumor DNA In Therapeutic Resistance

Articles from other publishers (9)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The Role Of Circulating Tumor DNA In Therapeutic Resistance

Citations (9)

Articles from other publishers (9)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date